| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Watson David O. is a General Counsel at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sell | 8,510 | $89.98 | $765,729.80 | -9.0% | -58.4% | -60.8% | |
| Jun 22, 2022 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sell | 10,000 | $44.51 | $445,140.00 | -8.0% | +44.5% | +97.0% | |
| Apr 25, 2022 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sell | 5,000 | $50.00 | $250,000.00 | -3.8% | +10.0% | +77.0% | |
| Dec 27, 2021 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sell | 1,200 | $48.50 | $58,200.00 | -1.1% | +0.5% | +2.7% | |
| Dec 22, 2021 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sale+OE | 10,571 | $47.81 | $505,372.62 | -3.2% | +13.2% | +8.1% | |
| Dec 14, 2020 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sale+OE | 18,333 | $50.94 | $933,947.48 | -5.5% | - | - | |
| Feb 10, 2020 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sale+OE | 5,000 | $44.50 | $222,500.00 | -12.4% | - | - | |
| Jan 27, 2020 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Sale+OE | 3,000 | $40.47 | $121,401.00 | -13.6% | - | - |